FI891012A0 - Förfarande och medel för kompensation av störfaktorer i immunologiska prov - Google Patents

Förfarande och medel för kompensation av störfaktorer i immunologiska prov

Info

Publication number
FI891012A0
FI891012A0 FI891012A FI891012A FI891012A0 FI 891012 A0 FI891012 A0 FI 891012A0 FI 891012 A FI891012 A FI 891012A FI 891012 A FI891012 A FI 891012A FI 891012 A0 FI891012 A0 FI 891012A0
Authority
FI
Finland
Prior art keywords
compensation
procedure
disturbance factors
immunological tests
substance
Prior art date
Application number
FI891012A
Other languages
English (en)
Finnish (fi)
Other versions
FI92879C (sv
FI891012A (sv
FI92879B (sv
Inventor
Helmut Lenz
Ellen Moessner
Werner Stock
Norbert Franken
Robert Crane Mccarthy
Albert Roeder
Harald Haug
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI891012A0 publication Critical patent/FI891012A0/sv
Publication of FI891012A publication Critical patent/FI891012A/sv
Application granted granted Critical
Publication of FI92879B publication Critical patent/FI92879B/sv
Publication of FI92879C publication Critical patent/FI92879C/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
FI891012A 1988-03-03 1989-03-02 Förfarande och medel för kompensation av störfaktorer i immunologiska prov FI92879C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16405488 1988-03-03
US07/164,054 US4914040A (en) 1988-03-03 1988-03-03 Reagent and method for determination of a polyvalent substance using an immunoaggregate

Publications (4)

Publication Number Publication Date
FI891012A0 true FI891012A0 (sv) 1989-03-02
FI891012A FI891012A (sv) 1989-09-04
FI92879B FI92879B (sv) 1994-09-30
FI92879C FI92879C (sv) 1995-01-10

Family

ID=22592781

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891012A FI92879C (sv) 1988-03-03 1989-03-02 Förfarande och medel för kompensation av störfaktorer i immunologiska prov

Country Status (18)

Country Link
US (1) US4914040A (sv)
EP (1) EP0331068B1 (sv)
JP (1) JPH0823560B2 (sv)
AT (1) ATE82072T1 (sv)
AU (1) AU616484B2 (sv)
CA (1) CA1340572C (sv)
DD (1) DD280396A5 (sv)
DE (2) DE3905505A1 (sv)
DK (1) DK175429B1 (sv)
ES (1) ES2045216T3 (sv)
FI (1) FI92879C (sv)
GR (1) GR3006991T3 (sv)
HU (1) HU212322B (sv)
IE (1) IE62974B1 (sv)
LV (1) LV10538B (sv)
PT (1) PT89889B (sv)
RU (1) RU2032906C1 (sv)
ZA (1) ZA891568B (sv)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3730059A1 (de) * 1987-09-08 1989-03-30 Behringwerke Ag Verfahren zur bestimmung von "loeslichem" fibrin
US5141853A (en) * 1988-07-22 1992-08-25 Abbott Laboratories Determination of ammonia levels in a sample
DE3829245A1 (de) * 1988-08-29 1990-03-01 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz
WO1991006559A1 (en) * 1989-10-24 1991-05-16 E.I. Du Pont De Nemours And Company Use of polymerized immunoglobulin to reduce the incidence of false-positive responses in immunoassays
US6274325B1 (en) 1990-06-25 2001-08-14 Boehringer Mannheim Gmbh Method for carrying out a homogeneous-immunoassay based on agglutination
DE4020204A1 (de) * 1990-06-25 1992-01-02 Boehringer Mannheim Gmbh Durchfuehrung eines homogenen immunoassays nach dem agglutinationsprinzip
JPH04350559A (ja) * 1991-05-28 1992-12-04 Dai Ichi Pure Chem Co Ltd 特異抗体の測定法
DE69217957T2 (de) * 1991-07-26 1997-08-07 Dade Chemistry Systems Inc Verfahren zur beseitigung von falschen ergebnissen in einem immunoassay
US5460944A (en) * 1991-10-28 1995-10-24 Boehringer Mannheim Gmbh Storable protein solution
DE4202923A1 (de) * 1992-02-01 1993-08-05 Behringwerke Ag Verfahren zur bestimmung von antigenen oder antikoerpern in gegenwart eines immunkomplexes
IL102495A (en) * 1992-07-14 1998-06-15 Patchornik Avraham Universal standard reagents, method of preparing same and use thereof
IL106887A (en) * 1993-09-02 1997-02-18 Yissum Res Dev Co Pharmaceutical and diagnostic compositions and a method for drug targeting
GB9403215D0 (en) * 1994-02-19 1994-04-13 Kodak Ltd Chemical modification of antibodies and antigens
DE4407423A1 (de) * 1994-03-05 1995-09-07 Boehringer Mannheim Gmbh Entstörmittel zum Einsatz bei Immunoassays
CA2184386C (en) * 1994-03-05 2005-10-18 Rosemarie Kientsch-Engel Interference eliminating agent for application in immunoassays
DE4439452A1 (de) * 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz
DE19621133A1 (de) * 1996-05-24 1997-11-27 Boehringer Mannheim Gmbh Bestimmungsverfahren mit oligomerisierten Rezeptoren
DE19731465A1 (de) * 1997-07-22 1999-01-28 Boehringer Mannheim Gmbh Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren
ATE225511T1 (de) * 1997-12-11 2002-10-15 Roche Diagnostics Gmbh Entstörung von diagnostischen verfahren durch peptide aus d-aminosäuren
DE19828466A1 (de) * 1998-06-26 1999-12-30 Roche Diagnostics Gmbh Entstörung von Immunoassays durch Substanzen, die aus den Framework-Regionen von Antikörpern abgeleitet sind
US6406858B1 (en) * 1998-11-27 2002-06-18 Bayer Corporation System for the reduction of interferences in immunoassays
JP2004510161A (ja) * 2000-09-25 2004-04-02 アボット・ラボラトリーズ 高分子ポリカチオンを用いることにより、特異的結合アッセイにおける血清または血漿含有アッセイ試料の干渉を減少させるための方法及びキット
DE10059720A1 (de) 2000-11-30 2002-06-06 Roche Diagnostics Gmbh Verwendung intramolekular kovalent vernetzter Proteine als Bindepartner in Immunoassays
DE10064827A1 (de) 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
US20040091952A1 (en) * 2002-07-25 2004-05-13 Sysmex Corporation Reagent kit for detecting lupus anticoagulant
US20040018556A1 (en) * 2002-07-29 2004-01-29 Cantor Thomas L. Reagent and method for determination of a substance using an immunoaggregator
DE602004016906D1 (de) * 2003-03-28 2008-11-20 Sysmex Corp Reagenz zum Nachweis von anti-Phospholipid Antikörper
CN1849514A (zh) * 2003-07-08 2006-10-18 因韦尔尼斯医药瑞士股份有限公司 颗粒凝集的检测方法和装置
US20050112586A1 (en) * 2003-11-24 2005-05-26 Roland Janzen Method and composition for stabilizing liquid reagents
DE602005006633D1 (de) * 2004-02-06 2008-06-26 Sysmex Corp Reagenziensatz zum Nachweis von Lupus-Antikoagulant.
CN1969189B (zh) * 2004-06-14 2012-03-21 协和梅迪克斯株式会社 非特异性反应被抑制的可溶性白介素-2受体免疫学测定方法和试剂
AU2005303388A1 (en) * 2004-11-15 2006-05-18 Inverness Medical Switzerland Gmbh Blood type method system and device
US7172906B2 (en) * 2004-11-16 2007-02-06 Dade Behring Inc. Reduction of non-specific binding in assays
EP2184608B1 (en) * 2007-08-23 2016-10-05 LSI Medience Corporation Non-specific reaction inhibitor
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2019207115A1 (en) * 2018-04-26 2019-10-31 Statens Serum Institut Improved immunoassays
CN109342743B (zh) * 2018-12-05 2022-02-18 菲鹏生物股份有限公司 一种能够与类风湿因子高效结合的变性IgG的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3266967D1 (en) * 1982-01-05 1985-11-21 Int Inst Cellular Molecul Path Method of immunoassay
DE3206729A1 (de) * 1982-02-25 1983-09-01 Behringwerke Ag, 3550 Marburg Immunologisches agglutinationsverfahren
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4474892A (en) * 1983-02-16 1984-10-02 Board Of Trustees Of The Leland Stanford Junior University Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
US4582810A (en) * 1983-09-30 1986-04-15 Becton, Dickinson And Company Immuno-agglutination particle suspensions
JPS60256057A (ja) * 1984-06-01 1985-12-17 Dai Ichi Pure Chem Co Ltd 免疫学的測定法
JPS6165162A (ja) * 1984-09-05 1986-04-03 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体を用いた免疫学的測定方法における非特異反応吸収剤
JPH0799372B2 (ja) * 1985-07-13 1995-10-25 富士レビオ株式会社 逆受身凝集反応用非特異反応吸収剤

Also Published As

Publication number Publication date
FI92879C (sv) 1995-01-10
JPH0823560B2 (ja) 1996-03-06
PT89889A (pt) 1989-11-10
AU3090889A (en) 1989-09-07
IE62974B1 (en) 1995-03-08
IE890683L (en) 1989-09-03
DE3905505A1 (de) 1989-09-14
DD280396A5 (de) 1990-07-04
EP0331068A1 (de) 1989-09-06
CA1340572C (en) 1999-06-01
LV10538A (lv) 1995-02-20
ATE82072T1 (de) 1992-11-15
RU2032906C1 (ru) 1995-04-10
DE58902586D1 (de) 1992-12-10
PT89889B (pt) 1994-05-31
FI891012A (sv) 1989-09-04
AU616484B2 (en) 1991-10-31
ZA891568B (en) 1989-11-29
DK175429B1 (da) 2004-10-18
GR3006991T3 (sv) 1993-06-30
LV10538B (en) 1995-12-20
HUT50988A (en) 1990-03-28
HU212322B (en) 1996-05-28
FI92879B (sv) 1994-09-30
DK96689A (da) 1989-09-04
DK96689D0 (da) 1989-02-28
EP0331068B1 (de) 1992-11-04
ES2045216T3 (es) 1994-01-16
US4914040A (en) 1990-04-03
JPH01254869A (ja) 1989-10-11

Similar Documents

Publication Publication Date Title
FI891012A0 (sv) Förfarande och medel för kompensation av störfaktorer i immunologiska prov
FI903515A0 (sv) Testförfarande och reagenskitt för detta
AU3395084A (en) Polypeptide-induced monoclonal receptors to protein ligands
FI89379B (fi) Bestaemning av glykosylerat hemoglobin i blodet
ES2033266T3 (es) Procedimiento y estuche de ensayo para la determinacion de sustancias activas libres en liquidos biologicos.
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
ATE107418T1 (de) Nachweis von analyt in partikel enthaltenden proben.
NO874783L (no) Fremgangsmaate for mengdebestemmelse av stabilt, glycosylert hemoglobin.
ES555425A0 (es) Un metodo de medida de la concentracion de un ligando libre en un fluido biologico
ES2054686T3 (es) Equipo de inmunoensayo.
FI87021B (fi) Foerfarande foer stabilisering av prostataspecifik antigen i naturella matriser och foerfarande foer framstaellning av matriser.
GB2011070A (en) Assay of vitamin B12
DE3863270D1 (de) Immuntest.
SE8000236L (sv) Forbettrat forfarande att framstella indikatorsystem for bestemning av reaktioner mellan antinger och antikroppar med hjelp av hemolys i gel
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: BOEHRINGER MANNHEIM GMBH

MA Patent expired